711 related articles for article (PubMed ID: 32677533)
1. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
Samad A; Ahammad F; Nain Z; Alam R; Imon RR; Hasan M; Rahman MS
J Biomol Struct Dyn; 2022 Jan; 40(1):14-30. PubMed ID: 32677533
[TBL] [Abstract][Full Text] [Related]
2.
Devi A; Chaitanya NSN
J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
[TBL] [Abstract][Full Text] [Related]
3. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
4. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
Jyotisha ; Singh S; Qureshi IA
J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
[TBL] [Abstract][Full Text] [Related]
5. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
6. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
7. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
Marchan J
J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
[TBL] [Abstract][Full Text] [Related]
8. A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.
Martin WR; Cheng F
J Biomol Struct Dyn; 2022 Sep; 40(15):7099-7113. PubMed ID: 33715598
[TBL] [Abstract][Full Text] [Related]
9. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
[TBL] [Abstract][Full Text] [Related]
10. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Almofti YA; Abd-Elrahman KA; Eltilib EEM
BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
[TBL] [Abstract][Full Text] [Related]
11. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
12. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach.
Bhatnager R; Bhasin M; Arora J; Dang AS
J Biomol Struct Dyn; 2021 Sep; 39(15):5690-5705. PubMed ID: 32619134
[TBL] [Abstract][Full Text] [Related]
13. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
14. Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins.
Rajput VS; Sharma R; Kumari A; Vyas N; Prajapati V; Grover A
J Biomol Struct Dyn; 2022; 40(19):9096-9113. PubMed ID: 34038700
[TBL] [Abstract][Full Text] [Related]
15. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
[TBL] [Abstract][Full Text] [Related]
16. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
17. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.
Sirohi PR; Gupta J; Somvanshi P; Prajapati VK; Grover A
J Biomol Struct Dyn; 2022 May; 40(8):3347-3358. PubMed ID: 33246394
[TBL] [Abstract][Full Text] [Related]
18. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
[TBL] [Abstract][Full Text] [Related]
19. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide.
Srivastava S; Verma S; Kamthania M; Agarwal D; Saxena AK; Kolbe M; Singh S; Kotnis A; Rathi B; Nayar SA; Shin HJ; Vashisht K; Pandey KC
J Biomol Struct Dyn; 2022 Mar; 40(5):2369-2388. PubMed ID: 33155524
[TBL] [Abstract][Full Text] [Related]
20. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an
Enayatkhani M; Hasaniazad M; Faezi S; Gouklani H; Davoodian P; Ahmadi N; Einakian MA; Karmostaji A; Ahmadi K
J Biomol Struct Dyn; 2021 May; 39(8):2857-2872. PubMed ID: 32295479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]